SELECTBIO - Extracellular Vesicles 2022: Technologies Driving Biological Investigations Biographies

Home

Agenda

Keynote Speakers

Registration

Exhibition

Venue

Training Courses

Co-Located Conferences

Early Cancer Detection Powered by Extracellular Vesicles Using the Verita™ AC Electrokinetic Chip

Tuesday, 13 December 2022 at 17:00

Add to Calendar ▼2022-12-13 17:00:002022-12-13 18:00:00Europe/LondonEarly Cancer Detection Powered by Extracellular Vesicles Using the Verita™ AC Electrokinetic ChipExtracellular Vesicles 2022: Technologies Driving Biological Investigations in Long Beach, CaliforniaLong Beach, CaliforniaSELECTBIOenquiries@selectbiosciences.com

Utilizing the power of AC Electrokinetic (ACE) technology, Biological Dynamics’ Verita™ lab-on-a-chip platform provides a unique isolation of extracellular vesicles (EVs) directly from blood. By analyzing the isolated EV protein cargo and applying machine learning, multi-cancer early detection (MCED) is enabled. The detection performance at high specificity for multiple histologies enables future applications in cancer diagnostics.

David Searson, Senior Engineer, Biological Dynamics

David Searson is a Senior Engineer in the R&D department at Biological Dynamics. His contribution to developing the Verita™ platform was instrumental in bringing the company’s first LDT to market as well as multiple granted patents and peer-reviewed publications. He holds a B.D degree in Bioengineering from the University of California, San Diego and has been an integral part of the Biological Dynamics team for 8 years.